Abstract
Purpose of Review
Acute Colonic Pseudo-obstruction (ACPO) is a cause of large intestinal dilation and obstruction without any physical transition point. It remains difficult to diagnose and treat. We review the recent updates on diagnosis and management of ACPO.
Recent Findings
Recent guidelines have posited that conservative management can be tried in most cases of ACPO, but that early decompression and surgery should be considered. Use of neostigmine is still a viable option but there is also promising data on pyridostigmine as well as prucalopride. Resolution of ACPO should be followed by daily use of polyethylene glycol (PEG) to help prevent recurrence.
Summary
ACPO warrants early and accurate diagnosis with exclusion of alternate causes of large bowel dilation. Conservative management can be attempted for 48-72 h in those with cecal diameters < 12 cm and without signs of peritonitis and perforation. Early escalation of management should be attempted with neostigmine followed by endoscopy and/or surgery as needed, given that longer periods of dilation are associated with worse outcomes. There is promising new evidence for use of pyridostigmine and prucalopride, but further trials are needed prior to incorporating them into regular use. Finally, studies are lacking regarding prevention of ACPO after initial resolution.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Vanek VW, Al-Salti M. Acute pseudo-obstruction of the colon (Ogilvie’s syndrome). An analysis of 400 cases. Dis Colon Rectum. 1986;29:203–10. https://doi.org/10.1007/BF02555027.
Ross SW, Oommen B, Wormer BA, Walters AL, Augenstein VA, et al. Acute Colonic Pseudo-obstruction: Defining the Epidemiology, Treatment, and Adverse Outcomes of Ogilvie’s Syndrome. Am Surg. 2016;82:102–11. https://doi.org/10.1177/000313481608200211.
Durai R. Colonic Pseudo-obstruction. Singapore Med J. 2009;50:237–44.
Ogilvie WH. Large-intestine Colic due to Sympathetic Deprivation. A new clinical syndrome. Dis Colon Rectum. 1987;30:984–7. https://doi.org/10.1007/BF02554291.
Pereira P, Djeudji F, Leduc P, Fanget F, Barth X. Ogilvie’s Syndrome-acute Colonic Pseudo-obstruction. J Visc Surg. 2015;152:99–105. https://doi.org/10.1016/j.jviscsurg.2015.02.004.
Ahmed S, Sharman T. Intestinal Pseudo-Obstruction. In: StatPearls [Internet]. StatPearls Publishing. 2022.
Schermer CR, Hanosh JJ, Davis M, Pitcher DE. Ogilvie’s syndrome in the Surgical Patient: A New Therapeutic modality. J Gastrointest Surg. 1999;3:173–7. https://doi.org/10.1016/s1091-255x(99)80029-8.
Underhill J, Munding E, Hayden D. Acute Colonic Pseudo-obstruction and Volvulus: Pathophysiology, Evaluation, and Treatment. Clin Colon Rectal Surg. 2021;34:242–50. https://doi.org/10.1055/s-0041-1727195.
•• Naveed M, Jamil LH, Fujii-Lau LL, Al-Haddad M, Buxbaum JL, et al. American Society for Gastrointestinal Endoscopy Guideline on the Role of Endoscopy in the Management of Acute Colonic Pseudo-obstruction and Colonic Volvulus. Gastrointest Endosc. 2020;91:228–35. https://doi.org/10.1016/j.gie.2019.09.007. Most recent guidelines on ACPO.
Dorudi S, Berry AR, Kettlewell MG. Acute Colonic Pseudo-obstruction. Br J Surg. 1992;79:99–103. https://doi.org/10.1002/bjs.1800790203.
Loftus CG, Harewood GC, Baron TH. Assessment of Predictors of Response to Neostigmine for Acute Colonic Pseudo-obstruction. Am J Gastroenterol. 2002;97:3118–22. https://doi.org/10.1111/j.1572-0241.2002.07108.x.
van der Spoel JI, Oudemans-van Straaten HM, Stoutenbeek CP, Bosman RJ, Zandstra DF. Neostigmine Resolves Critical Illness-related Colonic Ileus in Intensive Care Patients with Multiple Organ Failure–A Prospective, Double-blind, Placebo-controlled Trial. Intensive Care Med. 2001;27:822–7. https://doi.org/10.1007/s001340100926.
White L, Sandhu G. Continuous Neostigmine Infusion Versus Bolus Neostigmine in Refractory Ogilvie Syndrome. Am J Emerg Med. 2011;29(576):e1-3. https://doi.org/10.1016/j.ajem.2010.06.006.
•• Smedley LW, Foster DB, Barthol CA, Hall R, Gutierrez GC. Safety and Efficacy of Intermittent Bolus and Continuous Infusion Neostigmine for Acute Colonic Pseudo-Obstruction. J Intensive Care Med. 2020;35:1039–43. https://doi.org/10.1177/0885066618809010. First study to look at bolus vs infusion neostigmine with promising results.
İlban Ö, Çiçekçi F, Çelik JB, Baş MA, Duman A. Neostigmine Treatment Protocols Applied in Acute Colonic Pseudo-obstruction Disease: A Retrospective Comparative Study. Turkish J Gastroenterol. 2019;30:228–33. https://doi.org/10.5152/tjg.2018.18193.
Kram B, Greenland M, Grant M, Campbell ME, Wells C, et al. Efficacy and Safety of Subcutaneous Neostigmine for Ileus, Acute Colonic Pseudo-obstruction, or Refractory Constipation. Ann Pharmacotherapy. 2018;52:505–12. https://doi.org/10.1177/1060028018754302.
Lee KJ, Jung KW, Myung SJ, Kim HJ, Kim NY, et al. The Clinical Characteristics of Colonic Pseudo-obstruction and the Factors Associated with Medical Treatment Response: A Study Based on a Multicenter Database in Korea. J Korean Med Sci. 2014;29:699–703. https://doi.org/10.3346/jkms.2014.29.5.699.
Mankaney GN, Sarvepalli S, Arora Z, Kamal A, Lopez R, et al. Colonic Decompression Reduces Proximal Acute Colonic Pseudo-obstruction and Related Symptoms. Dis Colon Rectum. 2020;63:60–7. https://doi.org/10.1097/DCR.0000000000001492.
Harig JM, Fumo DE, Loo FD, Parker HJ, Soergel KH, et al. Treatment of Acute Nontoxic Megacolon During Colonoscopy: Tube Placement Versus Simple Decompression. Gastrointest Endosc. 1988;34:23–7. https://doi.org/10.1016/s0016-5107(88)71224-9.
Rex DK. Colonoscopy and Acute Colonic Pseudo-obstruction. Gastrointest Endosc Clin N Am. 1997;7:499–508.
Saunders MD. Acute colonic Pseudo-obstruction. Best Pract Res Clin Gastroenterol. 2007;21:671–87. https://doi.org/10.1016/j.bpg.2007.03.001.
Tsirline VB, Zemlyak AY, Avery MJ, Colavita PD, Christmas AB, et al. Colonoscopy is Superior to Neostigmine in the Treatment of Ogilvie’s syndrome. Am J Surg. 2012;204:849–55. https://doi.org/10.1016/j.amjsurg.2012.05.006.
Peker KD, Cikot M, Bozkurt MA, Ilhan B, Kankaya B, et al. Colonoscopic Decompression Should be Used Before Neostigmine in the Treatment of Ogilvie’s Syndrome. European J Trauma Emerg Surg. 2017;43:557–66. https://doi.org/10.1007/s00068-016-0709-y.
Alavi K, Poylin V, Davids JS, Patel SV, Felder S, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colonic Volvulus and Acute Colonic Pseudo-Obstruction. Dis Colon Rectum. 2021;64:1046–57. https://doi.org/10.1097/DCR.0000000000002159.
Hayden DM. Management of Acute Colonic Pseudo-Obstruction: What to Do When the Colon Is Doing Nothing. Dis Colon Rectum. 2022;65:1434–5. https://doi.org/10.1097/DCR.0000000000002649.
Sgouros SN, Vlachogiannakos J, Vassiliadis K, Bergele C, Stefanidis G, et al. Effect of Polyethylene Glycol Electrolyte Balanced Solution on Patients with Acute Colonic Pseudo Obstruction After Resolution of Colonic Dilation: A Prospective, Randomised, Placebo Controlled Trial. Gut. 2006;55:638–42. https://doi.org/10.1136/gut.2005.082099.
O’Dea CJ, Brookes JH, Wattchow DA. The efficacy of Treatment of Patients with Severe Constipation or Recurrent Pseudo-obstruction with Pyridostigmine. Colorectal Dis. 2010;12:540–8. https://doi.org/10.1111/j.1463-1318.2009.01838.x.
Manini ML, Camilleri M, Grothe R, Di Lorenzo C. Application of Pyridostigmine in Pediatric Gastrointestinal Motility Disorders: A Case Series. Paediatr Drugs. 2018;20:173–80. https://doi.org/10.1007/s40272-017-0277-6.
Di Nardo G, Viscogliosi F, Esposito F, Stanghellini V, Villa MP, et al. Pyridostigmine in Pediatric Intestinal Pseudo-obstruction: Case Report of a 2-year Old Girl and Literature Review. J Neurogastroenterol Motil. 2019;25:508–14. https://doi.org/10.5056/jnm19078.
•• Maleknejad A, Khazaei A, Bouya S. Evaluation of the Effect of Oral Pyridostigmine on the Ileus after Abdominal Surgery: A Blinded Randomized Clinical Trial. J Clin Med. 2018;7:104. https://doi.org/10.3390/jcm7050104. Largest study of pyridostigmine in adults with ileus.
Mendzelevski B, Ausma J, Chanter DO, Robinson P, Kerstens R, et al. Assessment of the Cardiac Safety of Prucalopride in Healthy Volunteers: A Randomized, Double-blind, Placebo- and Positive-controlled Thorough QT Study. Br J Clin Pharmacol. 2012;73:203–9. https://doi.org/10.1111/j.1365-2125.2011.04088.x.
Smart CJ, Ramesh AN. The Successful Treatment of Acute Refractory Pseudo-Obstruction with Prucalopride. Colorectal Dis. 2012;14:e508. https://doi.org/10.1111/j.1463-1318.2011.02929.x.
Primiano G, Plantone D, Forte F, Sauchelli D, Scaldaferri F, et al. Acute Refractory Intestinal Pseudo-obstruction in MELAS: Efficacy of Prucalopride. Neurology. 2014;82:1932–4. https://doi.org/10.1212/WNL.0000000000000458.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sen, A., Chokshi, R. Update on the Diagnosis and Management of Acute Colonic Pseudo-obstruction (ACPO). Curr Gastroenterol Rep 25, 191–197 (2023). https://doi.org/10.1007/s11894-023-00881-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11894-023-00881-w